7.75 - 8.39
0.2501 - 18.77
Join Discuss about OCGN with like-minded investors
$OCGN - a push towards 10.5 would be ideal $DATS - gonna see how 12.5 holds at the open...looking for $13-13.5 if we get there $GRVI - looking for 7 if we get there off open...otherwise gonna wait for 7.5 or 7.8s $AFRM - push off open for a rejection of 151 (high probability it will close below 150 today)
134 Replies 9 👍 10 🔥
IU Watchlist Main Watches: $DATS killer trap today nice swipe back ideally pushes and look for failed follow through post open. No sense trying to find top and as usual be aware of trappy action. $PLUG beautiful sell the news/catalyst event today - looking to fade any strength that fails. Higher better. Options doubled this morning! Failed Follow Through: $GRVI morning shove and looking to fade back. $BBIG pretty monster trade for anyone who took the big picture swing idea into catalyst - I'm not there anymore but looks like it worked out pretty perfect from Sunday scan. Continuation: $OCGN weak open and squeeze out then looking to join failed follow through.
61 Replies 15 👍 7 🔥
gonna add more at 10.5 OCGN
84 Replies 15 👍 6 🔥
IU Watchlist: Main Watches: $TTM monster parabolic chart - ideally $36 + parabolic and back side trade. Nothing to step in front and fight just looking to reactively trade and scale if right. $PLUG tried it a few times but never sized $33 was the level held each time tried it a few times sized in sized out sized in sized out and then bailed. Should be nice soon remember catalyst tomorrow. $OCGN impressive come back today - watch dips vs $9 or any good gap up $9.50 + squeeze out & unwind. Failed Follow Through: $DATS thinking gap down possible flush $8.50-9s $PROG thinking gap down flush $1.70-1.80s Continuation: $BMRA clean up day - still have core had sold each time over $7 (after the first time) around core looking to re scale if we firm up if not, I won't. $NXTP sold some AHs - closet slow pump but working well. Once it speeds up or trend fails should be great unwind as well.
110 Replies 12 👍 15 🔥
@Laz305 #Dark Pool Charts
Wu tang reversal? @DarkPoolAlgo OCGN?
108 Replies 10 👍 11 🔥
@Laz305 #Dark Pool Charts
OCGN looks bullish
123 Replies 6 👍 9 🔥
Next Dividend Date
Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. Its breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug - "one to many" and its novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. The Company is co-developing Bharat Biotech's COVAXIN™ vaccine candidate for COVID-19 in the U.S. market.
CEO: Shankar Musunuri
HQ: 5 Great Valley Pkwy Ste 160 Malvern, 19355 Pennsylvania